Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.
Founded in 1985 at Brembate (Bergamo) as a laboratory for the study of fluid bed granulation technology and its applications for the pharmaceutical and nutraceutical industry, Fine Foods & Pharmaceuticals N.T.M. very soon started to produce excipients and semifinished products.
Early 1989 the start for a "full time" activity as a contract manufacturer for oral solid forms dedicated to pharmaceutical and nutraceutical markets was given.
Later, new facilities for pharmaceuticals at Brembate (1991) and for nutraceuticals at Zingonia-Verdellino (1997), were opened. Over the years plant engineering has followed, and was adapted to, market requirements, strengthening in all solid oral forms (powder, granules,film-coated or plain tablets, hard-gel capsules) and virtually in every kind of packaging: sachets, bags, bottles, blisters, jars, tubes and strips. To complete pharmaceutical services another production plant was acquired early 2008 in Nembro (Bergamo), for toll-manufacturing production of tablets, film- and sugar-coated tablets as well as hard-gelatine capsules.
Last but not least Fine Foods & Pharmaceuticals N.T.M. installed lines for producing and packaging of monodose bottles for liquids, with or without cap for powders.
Main technology at Fine Foods & Pharmaceuticals N.T.M. is fluid bed granulation, by which instant soluble powders and effervescent forms are produced (granules, tablets).
Today Fine Foods & Pharmaceuticals N.T.M. is the biggest independent Italian contract manufacturer for nutraceuticals and an important player in the pharmaceutical market, with more than 330 employees, more than 150 customers and a global turnover of €80 million.